pharmaphorum February 10, 2025
As the AI Action Summit got underway in Paris this morning, dozens of corporations, investment groups, and technology providers revealed a new project that aims to “unlock Europe’s full potential” in the fast-evolving space.
The EU AI Champions Initiative, led by venture capital firm General Catalyst, is bringing together more than 60 organisations – including pharma giant Novo Nordisk and AI tech specialists that serve the industry like Owkin and Cradle.
The group is pushing for an EU-wide mobilisation of talent and capital and accelerating AI adoption by European companies to increase their competitiveness in a global market.
It wants to see simplified regulations, greater access to funding, investment in the infrastructure needed to support AI, and efforts to inform...
Today's Sponsors
Today's Sponsor